CSCs in many solid tumors, including cancers of the prostate, breast, pancreas, head and neck, and ovary have been identified using the cell surface adhesion molecule CD44, either individually or in combination with other cell surface markers such as CD133, integrin and ALDH1A19,12. This evidence concerns the gene CD44 and prostate carcinoma.